Early research (Phase 1)Study completedNCT02303678What this trial is testingD2C7 for Adult Patients With Recurrent Malignant GliomaWho this might be right forMalignant GliomaBrain Tumor, Recurrent Darell Bigner 81
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Not applicableLooking for participantsNCT05370079What this trial is testingControl Cohort CTRL COHWho this might be right forParkinson's Disease; Amyotrophic Lateral Sclerosis; Glioblastoma; Cancer Without Neurological Disease; Rheumatoid Polyarthritis Hospices Civils de Lyon 350
Testing effectiveness (Phase 2)Study completedNCT00058123What this trial is testingPoly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic GliomaWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 55
Testing effectiveness (Phase 2)Ended earlyNCT00074334What this trial is testingTP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade GliomaWho this might be right forBrain and Central Nervous System Tumors Pediatric Brain Tumor Consortium 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401What this trial is testingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsWho this might be right forSolid TumorsCNS Tumors Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Study completedNCT03566199What this trial is testingMTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine GliomaWho this might be right forDiffuse Intrinsic Pontine Glioma Sabine Mueller, MD, PhD 7
Testing effectiveness (Phase 2)Study completedNCT00086879What this trial is testingErlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors European Organisation for Research and Treatment of Cancer - EORTC 110
Early research (Phase 1)Looking for participantsNCT05857969What this trial is testingEx Vivo Drug Sensitivity Testing and Multi-Omics ProfilingWho this might be right forRecurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+15 more Florida International University 65
Early research (Phase 1)Study completedNCT03426891What this trial is testingPembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed GlioblastomaWho this might be right forGlioblastomaBrain TumorGBM H. Lee Moffitt Cancer Center and Research Institute 21
Early research (Phase 1)Study completedNCT00068510What this trial is testingVaccine Therapy in Treating Patients With Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Jonsson Comprehensive Cancer Center 28
Early research (Phase 1)Study completedNCT00002572What this trial is testingCytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain TumorsWho this might be right forBrain and Central Nervous System Tumors University of Colorado, Denver 10
Testing effectiveness (Phase 2)Temporarily pausedNCT06639607What this trial is testingPEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and EpendymomaWho this might be right forDiffuse Midline GliomaDiffuse Midline High-grade GliomaMedulloblastoma+1 more Washington University School of Medicine 68
Early research (Phase 1)Study completedNCT00509431What this trial is testingErlotinib and Sirolimus in Treating Patients With Recurrent Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Jonsson Comprehensive Cancer Center 19
Early research (Phase 1)Ended earlyNCT00826930What this trial is testingTrans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade GliomaWho this might be right forHigh Grade Glioma Diffusion Pharmaceuticals Inc 1
Large-scale testing (Phase 3)Study completedNCT00790400What this trial is testingEfficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)Who this might be right forTuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM) Novartis Pharmaceuticals 118
Not applicableStudy completedNCT03666507What this trial is testingVegetative Monitoring During Brainstem-associated SurgeryWho this might be right forBrain Tumor, RecurrentVestibular SchwannomaBrainstem Neoplasm+1 more University Hospital Tuebingen 103
Very early researchEnded earlyNCT02279992What this trial is testingPilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain MetastasesWho this might be right forGliomaBrain NeoplasmsBrain Metastasis Cedars-Sinai Medical Center 7
Not applicableStudy completedNCT03973892What this trial is testingRemote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation TherapyWho this might be right forGlioma Fondation Ophtalmologique Adolphe de Rothschild 58
Early research (Phase 1)Study completedNCT00730613What this trial is testingCellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors City of Hope Medical Center 3